Private Stem Cell Banking: Medical Services with Ambiguous Benefits
Room 133, Arts C Building, Sussex University
Private stem cell banking is a rapidly growing industry. In the US alone, the cord blood stem cell banking industry was estimated to be worth 3.4 billion USD in 2010. Yet, the benefits of storing stem cells for future personal use remain largely uncertain and unknown. Because of such ambiguity, many patients want to involve their physicians in the decision making process.
Based on his research conducted in the US, Sorapop Kiatspongsan will explore the barriers that exist to prevent an effective discussion between patients and physicians. These barriers include: differences between patients’ and physicians’ perceptions of benefits of stem cell banking and the physicians’ financial interests in stem cell banking companies.
Sorapop will also explore how insights from his research can inform policy recommendations for other medical services or products with similarly ambiguous future benefits.
Sorapop Kiatpongsan, is a physician, Lecturer in the Faculty of Medicine, Chulalongkorn University in Bangkok, Thailand and a Research Specialist at Massachusetts General Hospital, Harvard Medical School in Boston, USA. He is currently a Ph.D. candidate in Decision Sciences at Harvard University.
For inquiries: N.Chaisinthop@sussex.ac.uk